President Trump’s skepticism over vaccines and warnings over the safety of Tylenol is calculated to appeal to his supporters https://t.co/hrjFF3dClN ...

[Music] Moments ago, President Trump posted a litany of medical misinformation days after telling pregnant women not to take acetaminophen. He just posted this quote, "Pregnant women, don't use Tylenol unless absolutely necessary. Don't give Tylenol to your young children for virtually any reason. Break up the MMR shot into three totally separate shots, not mixed. Take chicken pea shot separately. Take hepatitis B shot at 12 years old or older. and importantly take vaccine in five separate medical visits be ...

If Tylenol is what causes autism are vaccines save now? ...

The FDA has approved the injectable version of Merc's cancer therapy, Kruda. That drug accounts for nearly half of Merc's revenue. And joining us right now on set is Robert Davis.He is the chairman and CEO of Merc. Also our very own Angelica Peebles. And welcome.It's good to see both of you. Uh Robert, let's talk about this first of all, the injectable version. Why is this better. Why will patients want this.>> Yeah. Well, well, first, you know, we're we're very excited about this because I do think this is ...

Group 1 - Fred Alger Management's "Alger Weatherbie Specialized Growth Fund" reported a 10.94% gain for Q2 2025, with Class A shares outperforming the Russell 2500 Growth Index [1] - Initial market volatility in April was due to trade policy uncertainty following President Trump's tariffs, but stability returned with a 90-day pause on new duties [1] - Market sentiment improved in May after the White House suspended reciprocal tariff hikes on China, contributing to the S&P 500 reaching a record high in June [1] Group 2 - Neogen Corporation (NASDAQ:NEOG) focuses on food and animal safety, but its stock experienced a -2.44% return over the last month and a 65.98% decline over the past 52 weeks [2] - As of September 23, 2025, Neogen's stock closed at $5.60 per share, with a market capitalization of $1.217 billion [2] - Neogen's performance was negatively impacted by fiscal third-quarter revenue and profitability falling below expectations, leading to a modest reduction in full-year 2025 guidance due to a weaker macroeconomic environment [3] Group 3 - Neogen Corporation was held by 28 hedge fund portfolios at the end of Q2 2025, an increase from 15 in the previous quarter, indicating growing interest [4] - Despite the potential of Neogen as an investment, certain AI stocks are viewed as having greater upside potential and lower downside risk [4]

Core Points - President Trump's recent press conference made unproven claims linking vaccines and acetaminophen to autism, which contradict established medical science [2][6] - TikTok has seen a surge in views related to these claims, with over 100 million views on videos discussing acetaminophen, vaccines, and autism in just 48 hours [4] - Major media outlets, including Fox News, have also propagated Trump's claims without providing necessary context or disclaimers [5] Company and Industry Analysis - TikTok's content policies prohibit harmful health misinformation, yet the platform has not responded to inquiries about whether the videos in question violated these policies [8] - The platform's previous efforts to combat medical misinformation have diminished as the COVID-19 pandemic has subsided, raising concerns about the spread of false information [7] - TikTok is in a precarious position regarding its relationship with Trump, who has the power to enforce a ban on the app in the U.S. and is involved in negotiations for its U.S. business sale [12]

President Donald Trump on Monday used the platform of the presidency to promote unproven and in some cases discredited ties between Tylenol, vaccines and autism as his administration announced a wide-... ...

Group 1 - Merck & Co., Inc. has received Breakthrough Therapy Designation from the FDA for raludotatug deruxtecan, targeting platinum-resistant ovarian, primary peritoneal, or fallopian tube cancers expressing CDH6 after bevacizumab treatment [2][3] - The designation is based on data from a phase 1 trial and the ongoing REJOICE-Ovarian01 phase 2/3 study, aimed at accelerating development for patients with significant unmet needs [3] - Approximately 65% of ovarian cancer patients express CDH6, and up to 80% experience relapse after standard therapies, highlighting the drug's potential impact [3] Group 2 - Merck & Co., Inc. is recognized as one of the best stocks to invest in for financial stability and is involved in developing pharmaceuticals, vaccines, biologics, and animal health products [1][4] - The collaboration between Merck and Daiichi Sankyo marks the second breakthrough designation for their oncology partnership, which began in October 2023 [3]

You watch a hearing like that and you see that there are so many layers to this, right. She's defending her personal credentials. There's the political pieces of this of, okay, Kennedy might have to come back and testify.A lot of us were watching Bill Cassidy who holds this really fascinating place as a Republican who will have to defend his seat in 2026, but he's also a physician. He's clearly concerned about what he's seen from Kennedy. And then, of course, there's the public health impact of it.Can you t ...

Chairman Cassidy, Ranking Member Sanders, and distinguished members of this committee, thank you for the opportunity to testify before you again. My name is Susan Monares, and I am a microbiologist and immunologist. Exactly 12 weeks ago in this same room, I testified that if confirmed, I would lead the CDC to restore public trust, modernize public health infrastructure, and strengthen the AY's core mission of protecting Americans from infectious diseases and emerging threats.I was honored to be nominated by ...